Biotech firm Maze Therapeutics, backed by Third Rock Ventures, revealed a profit for the first nine months of 2024 in its ...

Maze fits the mold of biotechs that have pulled off successful offerings recently: The seven-year old startup, which raised ...

Maze Therapeutics (MAZE), which is developing treatments for chronic kidney disease, has filed to raise $100M through an ...

Maze’s IPO comes on the heels of its oversubscribed Series D funding round, which infused the biotech with $115 million in ...

Just a month after announcing a $115 million series D financing to advance its lead assets, Maze Therapeutics is looking to ...

Maze Therapeutics has filed for an initial public offering with the Securities and Exchange Commission. The San Francisco-based human genetics biotech company didn't say Tuesday how many shares it ...

A tunnel which cost around £3 billion to construct to provide a sewage solution for a bustling city, could have another ...

TrampolineTales developer of the popular Luck be a Landlord slot machine deck-builder just announced Maze Mice and it really ...

Even with rain in the forecast, experts say it's "going to take months of rainfall and runoff to turn this thing around." ...